NextEra Energy, Inc. vs State Street SPDR S&P Biotech ETF — how do they compare? NextEra Energy, Inc. trades at $85.8 (market cap $178.85B), while State Street SPDR S&P Biotech ETF trades at $158.22. The key difference: NextEra Energy, Inc. pays a 2.91% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, NextEra Energy, Inc. nearer its low. Which is the better fit depends on your goals.
| NEE | XBI | |
|---|---|---|
Market Cap | $178.85B | — |
Sector | Utilities | Broad Market / Factor |
52-Week High | $97.88 | $164.28 |
52-Week Low | $69.77 | $86.92 |
Enterprise Value | $286.18B | — |
Dividend Yield | 2.91% | — |
Trailing returns across standard periods
NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.
Read more on NEE →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →